Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRA2A known ✓ | P08913 | 3/20 | 0.50 |
| ▸ | ADRA2B known ✓ | P18089 | 3/20 | 0.50 |
| ▸ | ADRA2C known ✓ | P18825 | 3/20 | 0.50 |
| ▸ | PTGS1 known ✓ | P23219 | 1/20 | 0.40 |
| ▸ | PTGS2 known ✓ | P35354 | 1/20 | 0.40 |
| ▸ | ADRA1D known ✓ | P25100 | 1/20 | 0.36 |
| ▸ | HRH3 known ✓ | Q9Y5N1 | 1/20 | 0.36 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.57 |
| ▸ | TSHR | P16473 | 3/20 | 0.42 |
| ▸ | POLB | P06746 | 5/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11595703 | 0.80 | TAAR1 (0.58) | TAAR1ADRA2AADRA2BADRA2CTSHR | |
| SCHEMBL9171406 | 0.77 | — | — | |
| SCHEMBL2030841 | 0.77 | TAAR1 (0.71) | TAAR1ADRA2AADRA2BADRA2CTSHR | |
| SCHEMBL9219690 | 0.76 | TAAR1 (0.64) | TAAR1ADRA2AADRA2BADRA2CTSHR | |
| Hydrochloric Acid SCHEMBL1222329 | 0.76 | — | — | |
| SCHEMBL9217680 | 0.73 | TAAR1 (0.66) | TAAR1ADRA2AADRA2BADRA2CTSHR | |
| SCHEMBL244450 | 0.73 | — | — | |
| Hydrochloric Acid SCHEMBL1535324 | 0.72 | TAAR1 (0.79) | TAAR1ADRA2AADRA2BADRA2CTSHR | |
| SCHEMBL20135772 | 0.72 | TAAR1 (0.73) | TAAR1ADRA2AADRA2BADRA2CTSHR | |
| SCHEMBL20146704 | 0.72 | TAAR1 (0.73) | TAAR1ADRA2AADRA2BADRA2CTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9907787-B2 | Method of supplementing the diet and ameliorating oxidative stress | EMERAMED LIMITED (IE) | 2018-03-06 | — | — | US | disclosed |
| US-20170172990-A1 | METHOD OF SUPPLEMENTING THE DIET AND AMELIORATING OXIDATIVE STRESS | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION | 2017-06-22 | — | — | US | disclosed |
| US-9592209-B2 | Method of supplementing the diet and ameliorating oxidative stress | EMERAMED LIMITED (IE) | 2017-03-14 | — | — | US | disclosed |
| US-20150265556-A1 | METHOD OF SUPPLEMENTING THE DIET AND AMELIORATING OXIDATIVE STRESS | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION | 2015-09-24 | — | — | US | disclosed |
| US-8950583-B2 | Method to remove heavy metals from a mammal | ERMES MEDICAL COMPANY LIMITED (IE) | 2015-02-10 | — | — | US | disclosed |
| US-20100227812-A1 | METHOD OF SUPPLEMENTING THE DIET AND AMELIORATING OXIDATIVE STRESS | EMERAMED LIMITED (IE) | 2010-09-09 | — | — | US | disclosed |
| EP-1355883-A2 | NOVEL MULTIDENTATE SULFUR-CONTAINING LIGANDS | The University of Kentucky Research Foundation (US) | 2003-10-29 | — | — | EP | disclosed |
| US-6586600-B2 | For removing metals from soils, water; pollution control; form stable, irreversible ligand-metal precipitates | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION | 2003-07-01 | — | — | US | disclosed |
| US-20020100732-A1 | Novel multidentate sulfur-containing ligands | CHELATOR TECHNOLOGIES, INC. | 2002-08-01 | — | — | US | disclosed |
| WO-2002049967-A2 | NOVEL MULTIDENTATE SULFUR-CONTAINING LIGANDS | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) | 2002-06-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150265556-A1 | METHOD OF SUPPLEMENTING THE DIET AND AMELIORATING OXIDATIVE STRESS | GPX4, GPX1, SOD1 | ADRA2A 2973/4885ADRA2B 2970/4885ADRA2C 2873/4885 |
| US-20100227812-A1 | METHOD OF SUPPLEMENTING THE DIET AND AMELIORATING OXIDATIVE STRESS | GPX4, GPX1, SOD1 | ADRA2A 2973/4885ADRA2B 2970/4885ADRA2C 2873/4885 |
| US-20170172990-A1 | METHOD OF SUPPLEMENTING THE DIET AND AMELIORATING OXIDATIVE STRESS | GPX4, GPX1, SOD1 | ADRA2A 2973/4885ADRA2B 2970/4885ADRA2C 2873/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.